Oxalobacter formigenes (O. formigenes) is an anaerobic gut bacterium that uses oxalate as its sole energy source. Oxalate is a natural compound in foods like spinach, nuts, and tea and is also produced by human metabolism. When oxalate is absorbed from the intestine, it is eliminated in urine, where it can bind calcium to form calcium oxalate crystals, the most common type of kidney stone. By breaking down oxalate inside the colon, O. formigenes reduces how much oxalate is available for absorption, which in turn lowers urinary oxalate and the likelihood of stone formation. In controlled diet studies, people colonized with O. formigenes excrete less urinary oxalate and have lower rates of recurrent calcium oxalate stones compared with those who are not colonized.
Biologically, O. formigenes performs two complementary actions. First, it degrades luminal oxalate, directly lowering the pool that could be absorbed. Second, it produces bioactive factors that stimulate the colon to secrete oxalate from blood back into the gut, adding a clearance route that further decreases urinary oxalate. Colonization appears common in many parts of the world but varies widely. It is antibiotic-sensitive, so courses of broad-spectrum antibiotics can eliminate it; conversely, colonization can sometimes be re-established with oral administration of the live organism.
Diet modifies both oxalate load and O. formigenes ecology. High dietary oxalate with adequate calcium at meals can reduce net absorption because calcium binds oxalate in the gut; very low calcium intake has the opposite effect, increasing absorption. Growth of O. formigenes is favored by oxalate availability, but higher calcium can lower its abundance by reducing soluble oxalate in the lumen. Because many other gut microbes contribute to oxalate degradation, a diverse oxalate-degrading network may protect against stones even when O. formigenes is absent.
Clinically, the most decision-relevant outcome is urinary oxalate, typically measured on a 24-hour urine collection in stone prevention clinics. Detecting O. formigenes itself is done on stool using culture, targeted PCR, or shotgun metagenomics. Presence does not always equal function: colonization can be low-grade, intermittent, or recently suppressed by antibiotics; stool assays differ in sensitivity; and host factors like fat malabsorption or inflammatory bowel disease can raise oxalate absorption independent of the microbiome. As a result, O. formigenes status should be interpreted alongside diet, medications, antibiotic history, and repeat urinary oxalate testing.
As a therapy, probiotic colonization with O. formigenes reliably lowers urinary oxalate in healthy adults under controlled conditions, but results in primary hyperoxaluria have been mixed, likely because endogenous oxalate production overwhelms colonic degradation capacity. That said, the bacterium’s secreted factors that drive colonic oxalate secretion are promising drug leads that may bypass colonization hurdles. For many stone-forming patients, a practical approach is to pair diet strategies that lower oxalate absorption with efforts to protect or restore oxalate-degrading microbes, then confirm benefit by tracking 24-hour urinary oxalate over time.